• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (55114981)   Find a Category (124)   Find a Journal (6146)   Find a Scholar (3941)   Find an Academic Assistant (17)
Find an Article PDF (4597353)   Today's Articles (0)   Subscriber (49354)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
For: Reck M, Paz-Ares L, De Marinis F, Molinier O, Prasad Sahoo T, Laack E, John W, Zimmermann A, Visseren-Grul C, Gridelli C. Paramount: Descriptive Subgroup Analyses of Final Overall Survival (OS) for the Phase III Study of Maintenance Pemetrexed (PEM) Versus Placebo (PLB) Following Induction Treatment with PEM Plus Cisplatin (CIS) for Advanced Nonsquamous (NS) Non-Small Cell Lung Cancer (NSCLC). Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33787-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]  Open
Number Cited by Other Article(s)
1
Paz-Ares LG, de Marinis F, Visseren-Grul C, Gridelli C. Reply to S. Barni et Al, K.R. Dearing et al, and N. Murray. J Clin Oncol 2014;32:483-5. [PMID: 24395851 DOI: 10.1200/jco.2013.53.6011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
2
Pérol M, Pérol D, Chouaid C. Reply to N. Singh et al. J Clin Oncol 2013;31:1251-2. [PMID: 23616988 DOI: 10.1200/jco.2012.47.8248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA